Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline.
作者信息
Wadi Jamal Ahmad, Selawi Fadi
出版信息
Ann Saudi Med. 2009 May-Jun;29(3):239-40. doi: 10.4103/0256-4947.51776.
Abstract
摘要
相似文献
1
Extended-spectrum beta-lactamase Klebsiella pneumoniae meningitis treated with tigecycline.
Ann Saudi Med. 2009 May-Jun;29(3):239-40. doi: 10.4103/0256-4947.51776.
2
Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient.
Ann Saudi Med. 2010 Sep-Oct;30(5):404-7. doi: 10.4103/0256-4947.67087.
3
Use of tigecycline for the treatment of prolonged bacteremia due to a multiresistant VIM-1 and SHV-12 beta--lactamase-producing Klebsiella pneumoniae epidemic clone.
Diagn Microbiol Infect Dis. 2008 Mar;60(3):319-22. doi: 10.1016/j.diagmicrobio.2007.09.017. Epub 2007 Nov 9.
4
In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
Antimicrob Agents Chemother. 2012 Aug;56(8):4516-8. doi: 10.1128/AAC.00234-12. Epub 2012 May 29.
5
Ceftazidime/avibactam use for carbapenem-resistant Klebsiella pneumoniae meningitis: a case report.
J Antimicrob Chemother. 2018 Jan 1;73(1):254-256. doi: 10.1093/jac/dkx358.
6
Ceftazidine-avibactam salvage therapy in newborn with KPC-producing Klebsiella pneumoniae invasive infections.
Minerva Anestesiol. 2019 Jul;85(7):804-805. doi: 10.23736/S0375-9393.19.13521-3.
7
[Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Zhonghua Shao Shang Za Zhi. 2015 Feb;31(1):5-8.
8
Use of Monte Carlo simulation to evaluate the efficacy of tigecycline and minocycline for the treatment of pneumonia due to carbapenemase-producing Klebsiella pneumoniae.
Infect Dis (Lond). 2018 Jul;50(7):507-513. doi: 10.1080/23744235.2018.1423703. Epub 2018 Jan 9.
9
Comparison of synergism between colistin, fosfomycin and tigecycline against extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates or with carbapenem resistance.
J Microbiol Immunol Infect. 2017 Dec;50(6):931-939. doi: 10.1016/j.jmii.2016.12.008. Epub 2017 Jul 6.
10
Tigecycline therapy for infections due to carbapenemase-producing Klebsiella pneumoniae in critically ill patients.
Scand J Infect Dis. 2014 Mar;46(3):175-80. doi: 10.3109/00365548.2013.861608. Epub 2013 Dec 20.
引用本文的文献
1
Intraventricular Plus Systemic Antibiotic Therapy for Treating Polymyxin-Resistant Ventriculitis: A Case Report.
Open Forum Infect Dis. 2022 Feb 15;9(4):ofac084. doi: 10.1093/ofid/ofac084. eCollection 2022 Apr.
2
Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.
Antimicrob Agents Chemother. 2011 Mar;55(3):1162-72. doi: 10.1128/AAC.01402-10. Epub 2010 Dec 20.
本文引用的文献
1
Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline.
Ann Saudi Med. 2007 Nov-Dec;27(6):456-8. doi: 10.5144/0256-4947.2007.456.
2
Extended-spectrum beta-lactamases and clinical outcomes: current data.
Clin Infect Dis. 2006 Apr 15;42 Suppl 4:S164-72. doi: 10.1086/500663.
3
The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data.
Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S354-67. doi: 10.1086/431676.
4
The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam.
Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S341-53. doi: 10.1086/431675.
5
Tigecycline: a new glycylcycline for treatment of serious infections.
Clin Infect Dis. 2005 Sep 1;41 Suppl 5:S303-14. doi: 10.1086/431672.
6
Outbreak of nosocomial sepsis and pneumonia in a newborn intensive care unit by multiresistant extended-spectrum beta-lactamase-producing Klebsiella pneumoniae: high impact on mortality.
Infect Control Hosp Epidemiol. 2001 Nov;22(11):725-8. doi: 10.1086/501855.
Zotero 插件